Status: Active source-quality and contamination concern; spirulina inclusion in pet food has plausible protein and pigment benefits but the heavy metal and microcystin contamination risk varies substantially by source. Spirulina is the common name for two species of cyanobacteria (blue-green algae): Arthrospira platensis and Arthrospira maxima. The organisms are filamentous photosynthetic prokaryotes that grow in alkaline freshwater and saltwater environments, with commercial cultivation primarily in Lake Texcoco (Mexico), Lake Chad (Africa), and large open-pond systems in China, India, Taiwan, the United States (California, Hawaii), and other regions. Spirulina is marketed as a "superfood" supplement for both human and pet applications based on its high protein content (typically 55-70% by dry weight, depending on cultivation conditions and processing), natural pigment content (phycocyanin blue pigment plus chlorophyll, carotenoids), essential amino acid completeness (most essential amino acids represented at non-limiting concentration relative to typical reference proteins), essential fatty acid content (gamma-linolenic acid in modest amounts), and vitamin content (B-vitamins, beta-carotene, and a contested form of vitamin B12 cobalamin analog that is not bioactive in humans or pets per current consensus). Pet food and supplement inclusion has emerged primarily in boutique and natural-positioning brands, with typical inclusion rates of 0.1-2% of dry matter. The contamination risk is the structural concern: spirulina can accumulate heavy metals (lead, arsenic, mercury, cadmium) from cultivation water and substrate sources, and can be co-cultivated or cross-contaminated with toxic cyanobacteria producing microcystins (potent hepatotoxic peptides). Both contamination risks vary substantially by source geography, cultivation method, and quality control protocols. The EU and US FDA have established maximum limits for heavy metals in spirulina supplements, and reputable manufacturers test routinely for microcystin contamination.

What was recalled

This page synthesizes the spirulina inclusion framework in commercial pet food and pet supplements. Spirulina refers to two species of cyanobacteria, Arthrospira platensis and Arthrospira maxima, that have been consumed by humans for centuries (notably by the Aztec civilization, who harvested from Lake Texcoco) and have been commercially cultivated as a dietary supplement since the 1970s. Cyanobacteria are taxonomically distinct from algae — they are photosynthetic prokaryotes (organisms without a nucleus) in the bacteria domain, while algae are eukaryotes (with a nucleus). The "blue-green algae" terminology applied to spirulina reflects the historical taxonomic confusion between bacteria and algae and the visible color of cyanobacterial mass.

Spirulina has been studied extensively for nutritional and pharmacological properties. The protein content is typically 55-70% by dry weight, which is exceptionally high among plant and microbial protein sources, with most essential amino acids represented at non-limiting concentrations. The amino acid profile compares favorably to most plant proteins but is somewhat deficient in methionine and cysteine (the sulfur amino acids) relative to animal protein, similar to the broader plant-protein pattern documented in our methionine source controversy page. The pigment content includes phycocyanin (a blue protein-pigment complex with antioxidant activity), chlorophyll (typical photosynthetic pigment), and carotenoids (beta-carotene and others) at meaningful concentrations. The essential fatty acid content includes gamma-linolenic acid (GLA, an omega-6 fatty acid with anti-inflammatory metabolic positioning) at modest concentrations.

The vitamin content deserves specific attention. Spirulina contains substantial B-vitamin content (riboflavin, thiamine, niacin, pantothenic acid, pyridoxine, folate) and beta-carotene. The vitamin B12 content is contested in nutrition science. Spirulina labels and marketing claims often emphasize high B12 content, but a substantial fraction of the cobalamin in spirulina is in a corrinoid form (pseudo-B12) that is not bioactive in humans and is not generally considered bioactive in companion animals. The bioactive B12 (cyanocobalamin, methylcobalamin, hydroxocobalamin) fraction is much lower than total cobalamin measurement suggests, and current consensus is that spirulina is not a reliable B12 source for B12-deficient individuals. The framework matters because vegan and vegetarian pet diets that rely on spirulina as a B12 source may face inadequacy concerns documented in our cobalamin B12 source controversy page.

Why it was recalled

The structural concerns have three layers. Layer one — heavy metal contamination varies by source: spirulina can accumulate heavy metals from cultivation water and substrate sources. Lead, arsenic, mercury, and cadmium are the heavy metals of greatest concern, with occasional reports of spirulina supplements exceeding safety thresholds. Source geography matters — spirulina cultivated in industrially polluted areas has produced higher heavy metal content in some surveys, while spirulina from well-managed cultivation facilities tested routinely shows much lower contamination. Reputable manufacturers test against international heavy metal limits (EU, US FDA, and equivalent international standards). Pet food brands using bulk-sourced spirulina without source verification or batch testing face elevated contamination risk relative to brands with documented supply-chain quality control.

Layer two — microcystin contamination from co-cultivation or cross-contamination: some toxic cyanobacterial species (Microcystis aeruginosa, Anabaena, others) produce microcystins, potent hepatotoxic cyclic peptides that can cause liver injury at acute high-dose exposure. Spirulina cultivation systems can experience microcystin contamination through co-cultivation with toxic species or environmental cross-contamination, particularly in open-pond cultivation systems. The World Health Organization has established a guideline limit of 1 microgram microcystin-LR per gram dry weight for microalgae supplements. Spirulina from reputable manufacturers is tested for microcystin content, while bulk-sourced material may not be. Pet food and supplement brands using spirulina without microcystin testing face risk of hepatotoxic contamination, with the clinical concern being chronic low-dose exposure producing hepatic injury that may not be immediately apparent.

Layer three — companion-animal therapeutic-effect evidence is limited: the canine and feline controlled-trial literature on spirulina supplementation is sparse. A few small canine studies have evaluated spirulina for immune support and exercise performance with mixed and modestly supportive results; veterinary clinical use for general adjunctive support exists at the level of complementary-medicine practice rather than evidence-supported guideline. The translation from human studies (mixed evidence for antioxidant, anti-inflammatory, immune-modulatory, and metabolic effects) and rodent studies to companion-animal therapeutic recommendation requires more controlled-trial work. Brands marketing spirulina inclusion for specific therapeutic effects in pets are operating ahead of the companion-animal evidence base.

Health risks for your pet

Spirulina at typical pet food and pet supplement inclusion rates from reputable manufacturers with documented quality control is generally well-tolerated and safe for dogs and cats. The mechanistic concerns include heavy metal contamination (most significant from bulk-sourced spirulina without source verification, less significant from quality-controlled sources tested against international heavy metal limits), microcystin contamination (potent hepatotoxin if present at significant concentration, with chronic low-dose exposure producing hepatic injury that may not be immediately apparent), rare allergic reaction in pets sensitized to cyanobacterial proteins, theoretical immunostimulant effect at higher doses that may be inappropriate for pets with autoimmune disease or on immunosuppressive therapy, and phenylalanine content (spirulina contains substantial phenylalanine, which is irrelevant for the vast majority of dogs and cats but is a consideration for the very rare phenylketonuria-like enzyme deficiency).

The pet-food-specific concern documented in some product surveys is that heavy metal contamination in pet supplements has been documented in third-party testing, with occasional product withdrawals related to heavy metal exceedances. Pet owners purchasing spirulina-containing pet supplements should prefer reputable brands with documented quality control, third-party testing, and source verification, rather than bulk-purchased or unverified products. The Animal Poison Control Center and similar resources track pet exposures to contaminated supplements when these occur.

What to do if you bought affected product

Pet owners can interpret spirulina pet food and supplement inclusion appropriately through several practical approaches: (1) prefer brands with documented quality control and third-party testing for heavy metals and microcystins; reputable manufacturers publish certificates of analysis or quality-control documentation on request; (2) avoid bulk-purchased or unverified spirulina supplements for pet use, particularly products imported from regions with elevated industrial pollution; the contamination risk for bulk-sourced material is meaningfully higher than for quality-controlled sources; (3) do not rely on spirulina as a vitamin B12 source for B12-deficient pets — the corrinoid pseudo-B12 fraction in spirulina is not bioactive in humans and is not generally considered bioactive in companion animals; B12 supplementation under veterinary guidance should use cyanocobalamin, methylcobalamin, or hydroxocobalamin rather than spirulina; (4) understand the companion-animal trial evidence gap — spirulina inclusion in pet food and pet supplements is supported by mechanistic plausibility and human and rodent studies but limited direct companion-animal controlled-trial evidence; aggregate "superfood" marketing positioning is not supported by current evidence at the level required for therapeutic recommendation; (5) watch for autoimmune disease and immunosuppressive therapy contexts — the theoretical immunostimulant effect at higher doses may be inappropriate for pets with autoimmune disease, on immunosuppressive therapy (cyclosporine, corticosteroids), or with active malignancy under chemotherapy; coordinate any supplementation with the prescribing veterinarian; (6) cross-check brand claims — brands marketing therapeutic-tier benefit at typical pet food inclusion rates without documented quality control are misrepresenting both contamination-risk safety and therapeutic-effect magnitude.

How this affects KibbleIQ’s grade

The KibbleIQ rubric v15 does not currently differentiate spirulina inclusion per our published methodology, since the contamination risk and companion-animal evidence base produce a complex evaluation framework. Future rubric extension under consideration: brands disclosing spirulina source geography, third-party testing protocols for heavy metals and microcystins, and certificate-of-analysis documentation would warrant scoring credit for transparency; aggregate "with spirulina" marketing claims without source or testing disclosure would warrant scoring caution rather than credit. The contamination-risk framework parallels concerns documented across our heavy metals pet food, Champion Petfoods heavy metals, and imported pet food ingredient controversy pages. For now, our recommendation: appreciate spirulina inclusion at moderate rates from reputable brands as a protein and pigment supplement, but require documented quality control on heavy metal and microcystin testing; do not rely on spirulina as a primary therapeutic intervention or as a vitamin B12 source.